The invention provides methods for preparing amorphous physical form of cabergoline, and solvate form A of cabergoline useful in the preparation of the first mentioned physical form. A method for treating a prolactin disorder with medicaments prepared from amorphous physical form of cabergoline and solvate form A of cabergoline is also disclosed.

 
Web www.patentalert.com

< Nucleic acids encoding Eph-like receptor tyrosine kinases

< Highly sulfated derivatives of K5 polysaccharide and their preparation

> Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them

> Compounds used to treat alcoholism
~ 00253